Literature DB >> 24622269

Dysglycaemia, vasculopenia, and the chronic consequences of diabetes.

Hertzel C Gerstein1, Geoff H Werstuck2.   

Abstract

High glucose concentrations are independent risk factors for many serious disorders. Glucose lowering can reduce or prevent many of these disorders. The mechanisms that cause glucose-linked tissue damage are unclear; however, the sequence of tissue changes that lead to one of these consequences (ie, retinopathy) have been understood for decades because the retina can be easily inspected and changes in its vascular supply can easily be assessed. The possibility that the long-term harms of raised glucose concentrations are mediated through reduced capillary perfusion (ie, vasculopenia) is suggested by strong epidemiological links between capillary abnormalities in the retina and most of the complications of diabetes, a delay between the therapeutic effect of glucose lowering in the retina and in other tissues, laboratory evidence that atherosclerosis is promoted by abnormalities in the capillary-rich vasa vasorum of conductance vessels, and similarities in capillary abnormalities in the retina and the kidney of people with diabetes. These findings also suggest that the retina might be a window through which the effect of raised glucose concentrations on a wide range of tissues can be seen. If continuing research lends support to this theory, treatments that counteract the effect of glucose on capillaries such as those in the retina might ultimately also reduce other serious consequences of dysglycaemia.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24622269     DOI: 10.1016/S2213-8587(13)70025-1

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN: 2213-8587            Impact factor:   32.069


  12 in total

1.  Diabetes: Dysglycaemia as a cause of cardiovascular outcomes.

Authors:  Hertzel C Gerstein
Journal:  Nat Rev Endocrinol       Date:  2015-07-28       Impact factor: 43.330

2.  Diabetes mellitus, prediabetes, and incidence of subclinical myocardial damage.

Authors:  Elizabeth Selvin; Mariana Lazo; Yuan Chen; Lu Shen; Jonathan Rubin; John W McEvoy; Ron C Hoogeveen; A Richey Sharrett; Christie M Ballantyne; Josef Coresh
Journal:  Circulation       Date:  2014-08-22       Impact factor: 29.690

3.  Retinal microvascular findings and risk of incident peripheral artery disease: An analysis from the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Chao Yang; Lucia Kwak; Shoshana H Ballew; Bernard G Jaar; Jennifer A Deal; Aaron R Folsom; Gerardo Heiss; A Richey Sharrett; Elizabeth Selvin; Charumathi Sabanayagam; Josef Coresh; Kunihiro Matsushita
Journal:  Atherosclerosis       Date:  2019-10-11       Impact factor: 5.162

4.  Nine-Year Effects of 3.7 Years of Intensive Glycemic Control on Cardiovascular Outcomes.

Authors: 
Journal:  Diabetes Care       Date:  2016-01-28       Impact factor: 19.112

5.  Diabetes, Brain Infarcts, Cognition, and Small Vessels in the Canadian Alliance for Healthy Hearts and Minds Study.

Authors:  Hertzel C Gerstein; Eric E Smith; Chinthanie Ramasundarahettige; Dipika Desai; Philip Awadalla; Philippe Broet; Sandra Black; Trevor J B Dummer; Jason Hicks; Alan Moody; Jean-Claude Tardif; Koon K Teo; Jennifer Vena; Salim Yusuf; Douglas S Lee; Matthias G Friedrich; Sonia S Anand
Journal:  J Clin Endocrinol Metab       Date:  2021-01-23       Impact factor: 5.958

6.  The Triglyceride-Glucose Index is Associated with Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes: A Hospital-Based, Nested, Case-Control Study.

Authors:  Litong Yao; Xinyu Wang; Yifan Zhong; Yan Wang; Jingyang Wu; Jin Geng; Yun Zhou; Jun Chen; Peng Guan; Yingying Xu; Lei Chen; Lei Liu; Yuedong Hu
Journal:  Diabetes Metab Syndr Obes       Date:  2021-04-09       Impact factor: 3.168

7.  Microvascular Outcomes of Pediatric-Onset Type 1 Diabetes Mellitus: A Single-Center Observational Case Reviews in Sana'a, Yemen.

Authors:  Abdallah Ahmed Gunaid
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2018-01-03

8.  Range of Risk Factor Levels: Control, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes Mellitus.

Authors:  Aidin Rawshani; Araz Rawshani; Stefan Franzén; Björn Eliasson; Ann-Marie Svensson; Mervete Miftaraj; Darren K McGuire; Naveed Sattar; Annika Rosengren; Soffia Gudbjörnsdottir
Journal:  Circulation       Date:  2017-02-22       Impact factor: 29.690

9.  Photoreceptor Degeneration Accompanies Vascular Changes in a Zebrafish Model of Diabetic Retinopathy.

Authors:  Zaheer Ali; Jingjing Zang; Neil Lagali; Nicole Schmitner; Willi Salvenmoser; Anthony Mukwaya; Stephan C F Neuhauss; Lasse D Jensen; Robin A Kimmel
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-02-07       Impact factor: 4.799

10.  Diabetic retinopathy as an independent predictor of subclinical cardiovascular disease: baseline results of the PRECISED study.

Authors:  Rafael Simó; Ignacio Ferreira; Jordi Bañeras; Cristina Hernández; José Rodríguez-Palomares; Filipa Valente; Laura Gutierrez; Teresa González-Alujas; Santiago Aguadé-Bruix; Joan Montaner; Daniel Seron; Joan Genescà; Anna Boixadera; José García-Arumí; Alejandra Planas; Olga Simó-Servat; David García-Dorado
Journal:  BMJ Open Diabetes Res Care       Date:  2019-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.